A novel in vivo mechanism for angiotensin type 1 receptor regulation  by Nishimura, Hideki et al.
Kidney International, Vol. 52 (1997), pp. 345—355
A novel in vivo mechanism for angiotensin type 1 receptor
regulation
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A novel in vivo mechanism for angiotensin type 1 receptor regulation.
This study examined whether a regulatory mechanism exists for the
angiotensin II receptor that is compatible with in vivo homeostatic need.
Experiments were conducted under two different experimental stresses,
(1) deletion of receptor protein and (2) chronic extracellular fluid (ECF)
volume depletion. To circumvent potentially dampening intermediary
feedback signals in vivo, any feedback gain was completely averted
through genetic engineering. The coding exon of angiotensin type 1A
(AT1A) receptor gene (Agtrla) was targeting-replaced with a reporter
gene, lacZ, so that the transcription of lacZ, instead of Agtrla, is driven by
the native Agtrla promoter. ECF volume depletion by dietary sodium
restriction enhanced Agtrla gene expression in the adrenal gland of
wild-type mice. However, although blood pressure fell in the homozygous
targeted mice,Agtrla gene expression remained unchanged in the adrenal,
indicating that adrenal Agtrla gene expression is regulated entirely
through angiotensin receptor-ligand interactions. In the kidney, AT1A
mRNA assessed by Northern blotting also did not change in AT1A
null-mutated mice with or without sodium restriction. However, tissue
examinations for lacZ mRNA and activities indicated that sodium restric-
tion and receptor protein depletion result in dramatic up-regulation of
Agtrla gene expression within the renal arterioles, which can be nullified
by an experimental normalization of blood pressure. No such change was
observed in wild-type mice. This study demonstrates a presence within the
resistance vessel of a blood pressure-sensitive mechanism for AT1 recep-
tor regulation that opposes a down-regulatory influence of the ligand
during ECF volume depletion.
Among the components of the renin-angiotensin system (RAS),
renin has long been thought to be the only rate-limiting step for
the biological actions of the system. However, recent human [1, 2]
and animal studies [3] have suggested that angiotensinogen as well
as angiotensin (Ang) I converting enzyme are also rate-limiting.
Most recently, convincing evidence has been obtained to indicate
that angiotensin type 1 (AT1) receptor can also be a quantitative
modulator for RAS function [4—6]. Thus, mice heterozygous for
target null mutation of the AT1A receptor gene had mean
systemic blood pressure that was some —20 mm Hg lower than
wild-types in association with quantitatively less tissue AT1A
mRNA.
Apart from this significant quantitative impact of receptor
mRNA on blood pressure, it remains uncertain whether AT1
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receptor is regulated by prevailing homeostatic needs. In this
regard, radioligand-receptor binding studies in rats showed that
dietary sodium restriction leads to a decrease in glomerular Ang II
receptor binding [7, 8], which is speculated to be driven by high
plasma Ang II [9]. Indeed, both acute and chronic infusions of
Ang II were shown to cause a significant reduction in Aiig II
binding sites in the rat glomerulus [8, 10]. Further studies revealed
that this down-regulation entirely reflects a reduction of Ang II
cell surface binding [8]. However, Ang II may be but one of
multiple mechanisms regulating its receptor during dietary so-
dium restriction. Moreover, little information is available as to the
status of extra-glomerular renal receptors, especially in the arte-
rioles and tubules, that may have an even greater functional
significance in regulating renal blood flow, glomerular filtration
and tubule reabsorption.
In this regard, assessment of receptor mRNA provides intrigu-
ing although conflicting information. Thus, in vitro exposure of
glomerular mesangial cells to Ang II for up to 24 hours did not
affect AT1 mRNA expression in one study [8]. In contrast, Makita
et al reported down-regulation of AT1 mRNA in rat mesangial
cells exposed to Ang II [11]. In rabbits, a sodium deficient diet for
four weeks led to a 43% increase in glomerular AT1 mRNA [12].
These diverse observations may be attributed to heterogeneity of
renal cells, that is, epithelial, endothelial, and mesangial cells, in
which AT1 mRNA may be differentially regulated. Perhaps more
importantly, even if some Ang lI-independent regulatory mecha-
nism exists for AT1 receptor, it may be difficult to document in the
in vivo setting due to the restoration of steady state. In this
connection, reduced renal perfusion pressure, which is presumed
to be the triggering signal for Ang II up-regulation during dietary
salt restriction, is commonly not documentable. Identification of
receptor regulatory mechanisms that promote re-establishment of
a steady state, therefore, requires an experimental design that
averts a gain of receptor regulation, such as normalization of
blood pressure, so that intermediary signal(s) remain fully acti-
vated. DNA recombinant technology allows such an experimental
design, that is, targeting replacement of the coding exon of the
mouse AT1A receptor gene (Agtrla) with a reporter gene (Fig. 1).
Unlike rats, AT1A is by far the predominant subtype of AT1
receptor in the mouse [13]. In this setting, transcription of the
reporter gene is still driven by the native AT1 gene promoter so
that AT1 gene activity can be monitored by tracking the level of
reporter gene product while averting the functional consequence
of altered ATI gene activity, since no AT1 gene product is made.
Our study found that both ECF volume depletion and receptor
345
AT1A Receptor Inhibition
or
Dietary Salt Restriction
Active Signal(s)
amperzirg77C galactosidase activiwTi Ap-fr -
______Agtrla _______
Agtrla promoter
Mutated Allele
Fig. 1. Experimental strategy employed in the
present study to uncover regulatory
mechanisms for angiotensin type 1A (AT1A)
receptor that may be masked in vivo. Targeting
replacement of the AT1A coding exon with a
reporter gene, lacZ, averts the gain of receptor
regulation that occurs in normal wild-type mice,
so that intermediary signal(s) remain fully
activated while altered transcription of the
AT1A receptor gene (Agtrla) can be
quantitatively monitored as lacZ mRNA or J3-
galactosidase activity. hgrr is the hygromycin
resistance gene, which is used to clone targeted
embryonic stem cells that were produced in the
process of generating Agtrla null mutant mice.
depletion lead to a dramatic up-regulation of Agtrla gene expres-
sion in the small renal arteries and arterioles. However, up-
regulation in the renal vasculature is mediated not by a local
angiotensin Il—receptor interaction, but by a systemic mechanism
such as reduction in renal perfusion pressure. This contrasts to the
regulation within the adrenal gland where the receptor is regu-
lated directly by the ligand.
METHODS
Animals
Wild-type mice and mice hetero- or homozygous for Agtrla
gene null mutation were used in this study. These arc the offspring
of the Agtrla deletion mutants generated earlier by gene targeting
in our laboratory [6].
Two lines of Agtrla null mutant mice were used in the present
study. One carries mutant AgtrIa allele where the ClaI-EcoRI 190
bp fragment in the Agtrla coding region was replaced with the
green fluorescence protein gene (GFP) [14], and a neomycin
resistance gene expression cassette, c4gtrlaatP) The other
has a mutation in Agtr1a' where the lacZ gene (lacZ) and a
hygromycin resistance gene expression cassette (hgrr) were, fi
stead, incorporated (Ag1rlalZ). Both gfj and lacZ genes were
fused with the Agtrla gene at the end of the third transmembrane
region in frame, so that both GFP and lacZ fusion proteins are
expected to he produced under the control of the endogenous
Agtrla promoter and anchored to the cell membrane. The embry-
onic stem cell line used in the above gene targeting is derived from
strain 129 (E14. I). The chimeric mice carrying Agtr1a' or
Agtr1alZ were mated with I 29/Svev (Taconic Farms Inc., Ger-
mantown, NY, USA) females, and raised into 129 inbred mice
carrying GFP or lacZ (Fig. 2) to avoid variation in genetic
background among individual animals. The genotypes of these
mice were screened by Southern blot analysis of tail DNA as
previously described [6]. F3 and F4 generation of wild-type (+1+),
heterozygous (Agtr1aZ/+) and homozygous (Agtr1alZI
Agtr1aZ, mice (Fig. 2) were subjected to
the analyses specified below.
Mice of each genotype were divided into two different dietary
groups and fed either normal mouse chow (0.46% Na; Purina
Mills, St. Louis, MO, USA) or low sodium purified diet (0.02%
Na). All animals had free access to diet and tap water and were
maintained in a virus- and pathogen-free animal facility for two
weeks until sacrifice. Six wild-type mice were used to study the
differential expression of Agtrla and Agtrlb, and ten mice of each
genotype (normal diet N = 5, low sodium diet N = 5) were
subjected to the separate experiments specified below. Six addi-
tional Agrrla—/— mice were placed on mineralocorticoid plus
high sodium regimen (mineralocorticoid plus salt) [15]. Mineralo-
corticoid administration was performed subcutaneously three
times per week and consisted of either a 25 mg/kg dose of
fludrocortisone acetate (Sigma Chemical Co., St. Louis, MO,
USA) suspended in peanut oil, or peanut oil alone (vehicle), in a
volume of 10 ml/kg body wt. These mice were fed normal mouse
chow and were given water containing 1% NaCI and 0.2% KCI, or
tap water (vehicle). All experiments were undertaken at 8 to 12
weeks of age. Care of the mice used in these experiments met the
standards set forth in the "Guidelines for Care and Use of
Experimental Animals" from the National Institutes of Health
(Bethesda, MD, USA). Procedures employed were approved by
Vanderbilt University Animal Care Committee.
Differential expression of Agtrla and Agirib
Total RNA was isolated from the heart, kidney and adrenal
gland with RNAzol °B (TEL TEST Inc., Friendswood, TX, USA)
[16] and dissolved in nuclease-free water. Concentration of RNAs
were estimated by absorption at 260 nm with a spectrophotometer
(Hitachi Ltd., Tokyo, Japan), and the samples were stored at
—70°C until assay.
Reverse-transcriptase polymerase chain reaction (RT-PCR)
was used to quantitate the expression of angiotensin type 1
receptor subtypes in the kidney, heart and adrenal gland of
wild-type mice (+1+: normal diet N = 3, low sodium diet N = 3)
as follows: Ten jig of total tissue RNA was treated with 2.0 units
of RQ1 RNase-free DNase (Promega, Madison, WI, USA) in 40
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and 200 units reverse transcriptase (Superscript°'° II; Gibco BRL)
in a 20 jil volume. The samples were incubated at 25°C for 10
minutes, shifted to 42°C for 50 minutes, and the reaction was
stopped at 70°C for 15 minutes. Then, the samples were immedi-
ately placed on ice, and 10% of the first strand reactions were used
for PCR amplification.
PCR was carried out in a 50 1u1 mixture of 1 mrvi MgC12,
nucleotide triphosphates (200 jiM each), 5% (vol/vol) dimethyl
sulfoxide, and 1 unit Taq polymerase and 20 pmol forward and
reverse primers used by others previously, 5'-GCATCATCTTT-
GTGGTGGG-3' and 5'-GAAGAAAAGCACAATCGCC-3' [13].
Thermal profile, performed with a thermal cycler (PTC-100'°; Mi
Research Inc. Watertown, MA, USA), consisted of denaturation
at 94°C for one minute, annealing at 58°C for one minute, and
extension at 72°C for two minutes for 35 cycles, followed by a final
extension at 72°C for five minutes. The PCR products, 640 bp in
length, derived only from Agtrla have an EcoRI site within the
amplicon. To distinguish Agtrla and Agtrlb, therefore, the reac-
tion products were digested with EcoRI, then electrophoresed on
1.2% agarose gels. Simultaneously, PCR of genomic DNA was
undertaken, digested with EcoRI and electrophoresed on the
same agarose gels as a control to verify the fidelity of PCR
reaction of both genes, and complete digestion. The hands of the
PCR products were scanned with a scanner (JX-330M; Sharp Co.,
Osaka, Japan) and the ratio between AT1A and AT1B RT-PCR
amplicons was semiquantitated by image analysis software (NIH
Image). Since the intensity ratio between both amplicons from
genomic DNA was approximately 450/640, reflecting their molec-
ular size ratio, the quantitative molecular ratio between the two
PCR products was 1:1. We, therefore, normalized all the data for
this molecular size ratio.
Northern blot analysis for AT1A and LacZ mRNAs
Fig. 2. Schematic presentation of mice with four different genotypes used
in the present study. These are: (1) wild-type mice (+1+) carrying two
intact angiotensin type 1A receptor gene (Agirla) alleles; (2) heterozygous
mice (Agtr1aIZ/+) carrying one intact Agtrla allele and one null mutated
allele (Agtr1acZ); and (3) homozygous mice carrying two null mutated
alleles. The mutated allele of heterozygotes was produced by replacing the
Agtrla coding exon with lacZ gene (lacZ). Some homozygotes carry two of
these lacZ-replacing alleles Agtr1atcZ/Agtr1aIZ), and others carry one
lacZ-replacing allele and one g/j-replacing allele (AgtrIaZ/AgtrIa),
where green fluorescence protein gene (gJ) is, as lacZ, a reporter gene.
Transcription of all these genes in wild-type and hetero- and homozygous
mice is driven by the native Agtrla promoter.
mM tris(hydroxy-methyl)aminomethane-HCI pH 8.0, 10 mM NaCI,
6 mist MgCl2, 10 mist CaCl2, and 26 units RNase inhibitor
(RNasin°'°; Promega) for 30 minutes at 37°C. The RNA was
extracted twice with phenol-chloroform and once in chloroform,
followed by ethanol precipitation to inactivate the DNase before
the PCR. The absence of DNA contamination was confirmed by
RT-PCR reactions lacking reverse transcriptase but otherwise
treated identically.
First strand eDNA was synthesized by mixing two jig of
denatured total RNA in a buffer consisting of 50 mist Tris-HCI pH
8.3, 75 mist KC1, 3 mist MgC12, 10 mM dithiothreitol (DTT), 26
units RNasin, 200 ng random primers (Gibco BRL, Grand
Island, NY, USA), 0.5 mist deoxynucleotide triphosphates (dNTP)
Northern blot analysis was performed as described elsewhere
[17]. Briefly, either 20 jig (for the kidney or heart) or 10 jig (for
the adrenal gland) of RNAs were electrophoresed in 1% agarose,
2.2 M formaldehyde and MOPS buffer gel, transferred to a nylon
membrane (Hybond°"-N+; Amersham Life Science Inc., IL,
USA) and hybridized with 32P-labeled probe specific for the
Agtrla coding exon or lacZ. Following hybridization, the mem-
branes were washed in 2 X SSC (1 X SSC; 0.15 M NaC1, 0.015 M
sodium citrate) and 0.2 X SSC in 0.1% SDS. The membrane was
re-hybridized with a human glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) eDNA probe (CLONTECH, Palo Alto, CA,
USA) as a control for RNA loading. The band of each specific
mRNA was identified and semiquantitated with an image analyzer
(Molecular Dynamics, Sunnyvale, CA, USA).
The Agtrla probe was the HindIIl-BglII 0.3 kb fragment in the
3' untranslated region of this gene. This fragment had an ex-
tremely low homology (< 10%) to mouse Agtrlb. A 0.8 kb Not
I/Cia I fragment in the coding regions of lacZ was also used for
quantitation of lacZ expression.
Histochemical analysis and -galactosidase staining
After sacrificing the animals, half of the heart and one of the
kidneys and adrenal glands of all mice were used for histochem-
ical analysis.
The tissues of mice heterozygotes (Agtr1alZ/+) or homozy-
gotes (Agtr1a''?/Agtrla1') were stained with -galactosidase.
Agtrla +1+
Fig. 4. Plasma angiotensin II levels for wild-type mice and mice homozy-
gous for Agtrla null mutation fed normal (U) or low (U) sodium diet.
During normal diet, a markedly elevated plasma angiotensin II level was
observed in AT1A receptor-deleted mice. In wild-type mice, there was a
significant increase during low sodium diet when compared to normal
sodium diet. Open bars represent mice fed normal sodium diet and solid
bars represent mice fed low sodium diet. Values are expressed as means
SEM. ns, not significant.
Fig. 3. An EcoRt site is present in the coding exon of the AT1A receptor
gene (Agtrla) but not in the AT1B receptor gene (Agtrlb), which allows
transcripts of these two genes to be distinguished. RT-PCR amplicons
produced using primers 1 and 2 specified in the Methods section were
digested with EcoRI. Products of AT1A appear as a 450 bp band and a 190
bp band while those of AT1B will appear as a single 640 bp band. Since the
intensity ratio between these two amplicons from genomic DNA was
approximately 450/640, reflecting their molecular size ratio, the quantita-
tive molar ratio between the two PCR products was 1:1, indicating that the
transcriptional efficiency of the two genes is essentially identical, and
EcoRI digestion is complete. We normalized all the data for this molecular
size ratio. Average values from three specimens each indicate that AT1A
mRNA predominates AT1B in the kidney, heart and adrenal gland in the
mouse. Symbols in B are: (U) AT1B mRNA; (U) AT1A mRNA.
Two mM-thick tissue slices were fixed in 4% paraformaldehyde
(PFA) at 4°C for two hours. Tissues were rinsed in [0.02%
Nonidet P40, 0.01% Na-deoxycholate, phosphate buffered saline
(PBS)] three times for five minutes each, and then stained in [2
mM MgCl, 0.02% Nonidet P40, 0.01% Na-deoxycholate, 20 mM
Tris-HC1, pH 7.4], 5 mvt K3Fe(CN)(, 5 mivi K4Fe(CN)6, 1 mg/mi
Bluo-Gal (Gibco BRL) in PBS (pH 7.4)] at 37°C for 48 hours.
After staining, tissues were rinsed as above and fixed again with
4% PFA for 24 hours at 4°C, embedded in paraffin and 3 sm
sections prepared. The specimens were counter-stained with
periodic acid-Schiff reagent without hematoxylin, Vascular areas
with positive f3-gaiactosidase staining were traced with the aid of
a camera lucida attachment. The traced areas were scanned with
JX-330M scanner and determined by NIH image. Cumulative
-galactosidase-positive vascular area was normalized by total
cortical area to obtain the density of -galactosidase-positive
vascular structure.
In situ hybridization
Both the Agtria and lacZ specific probes were the same
fragment as used for Northern blot analysis, which was subcloned
into pSP72 vector (Promega), allowing the generation of both
sense and antisense probes. Tissues for in situ hybridization were
fixed overnight in 4% PFA at 4°C, processed routinely, embedded
in paraffin and stored at 4°C until used for hybridization studies.
The in situ hybridization protocol was performed as described
previously with slight modifications [18]. Three micrometer sec-
tions were cut and placed on microslides (Superfrost Pius°'; VWR
Scientific, West Chester, PA, USA). Sections were dewaxed in
xyiene, then hydrated serially in 100% to 30% ethanol. They were
refixed in 4% paraformaldehyde for 20 minutes, washed in PBS,
and then treated with 20 iig/ml proteinase K for five minutes.
Subsequently, sections were acetylated with 0.4% (vol!voi) acetic
anhydride in 0.1 M triethanolamine for 10 minutes twice. After
rinsing in PBS, sections were successively dehydrated in 30% to
100% ethanol and air-dried. Sections were covered with 100 pi of
hybridization mixture containing 35S-labeled cRNA probe (2 X
io cpm/rl), 50% deionized formamide, 10% dextran sulfate, 8
ifiM DTT, 0.2 mg/ml tRNA, 0.02% Ficoli and 0.02% BSA, then
incubated overnight at 50°C in a sealed humidified container.
After hybridization, the slides were washed in 50% formamide,
2 >< SSC, 100 mrvi DTT at 65°C for 20 minutes, and treated with
20 mg/ml RNase A at 37°C for 30 minutes. Sections were washed
in 2 x SSC, followed by 0,1 X SSC at 65°C, dehydrated in 30% to
100% ethanol with 0.3 M ammonium acetate, and air-dried. They
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Fig. 5. AT1A mRNA from wild-type (+1+) and lacZ mRNA from homozy-
gous null mutant, Agtr1a'°2IAgtr1a" mice (—I—). Comparison of mice
on normal diet and mice of the same genotype on sodium restriction. In
kidney and heart, the ratio was, on average, one for both wild-type and
homozygous null mutant mice. In contrast, in the adrenal gland, AT1A
mRNA increased to levels > threefold of baseline during sodium restric-
tion over levels obtained during normal sodium. Sodium restriction has
little impact on lacZ mRNA expression in homozygous null mutants. The
ratio between AT1A mRNA and lacZ mRNA determined in the heterozy-
gates was used as a normalization factor in direct comparison between
AT1 mRNA from wild-type and lacZ mRNA from homozygotes. Values
are expressed as means SEM. N = 5 for each genotype. ns, not
significant.
were dipped in photographic emulsion (Ilford K2 emulsion; Ilford
Ltd., Basildon, Essex, UK) diluted in 2% glycerol solution,
air-dried, and exposed at 4°C for two to three weeks. After
development with D-19 developer, the slides were counterstained
with 0.02% toluidine blue.
Blood pressure measurement
At the end of two weeks, mice of each genotype (normal diet
N = 5, low sodium diet N = 5) were anesthetized with an
intraperitoneal injection of mactin® (100 mg/kg body wt; BYK,
Konstanz, Germany) [19] and placed on a temperature-controlled
warm table. PE 10 tubing (Becton Dickinson and Company,
Sparks, MD, USA), heated and tapered at one end, filled with a
heparin (100 U/ml)-saline solution, was inserted into the left
carotid artery. Blood pressure was measured with a Cobe CDXIII
transducer which was connected to a MicroMed BP Analyzer
(Micro-Med, Inc. Louisville, KY, USA). Blood pressure and heart
rate were continuously monitored for 30 minutes.
Plasma angiotensin II assay
Mice were sacrificed by decapitation and 0.5 ml blood was
collected into tubes containing 5 mvt EDTA and Bestatin (angio-
tensinase inhibitor; ALPCO, Windham, NH, USA). After centrif-
ugation, plasma was frozen and stored at —20°C until assay.
Plasma angiotensin II was measured by a double-antibody radio-
immuno assay using a commercial kit (ALPCO) [20]. Reversed
phase-extracted plasma samples and standards were incubated at
4°C for 16 hours with anti-angiotensin II antibody. 1251-angioten-
sin II then competed with angiotensin II present in samples and
standards for the same antibody binding sites. After a second
six-hour incubation, the solid-phase second antibody was added to
the reaction mixture and the antibody-bound fraction was precip-
itated and then counted with a y-counter (Gamma 5500; Beckman
Instruments, Irvine, CA, USA).
Statistical analysis
Data are presented as means SEM. Statistical analysis was
performed using Mann-Whitney test and ANOVA followed by
Tukey post hoc tests for multiple comparisons.
RESULTS
Differential expression of Agtrla and Agtrlb
An EcoRI site present in Agtrla but not in Agtrlb coding exons
allows transcripts of these two genes to be distinguished. This
approach of analyzing RT-PCR products revealed that the tran-
scripts in the kidney, heart and adrenal gland are primarily AT1A
during normal sodium diet (Fig. 3). The proportion of AT1A
mRNA among the entire PCR amplicon of AT1 transcripts
averaged 96.5 0.6%, 96.1 0.6 and 72.2 0.5 in the heart,
kidney and adrenal gland, respectively. This ratio was unchanged
in mice placed on low sodium diet (data not shown). The
quantitative ratio between the PCR products amplified on
genomic DNA for AT1A versus AT1B was - 450:640 (Fig. 3) and
reflected their molecular size ratio. Thus, these percentage values
were not attributed to potential differences in the efficiency of
PCR amplification between AT1A versus AT1B mRNA nor
partiality of digestion of the amplicons by EcoRI. The results,
instead, confirm the notion that the AT1A receptor overwhelm-
ingly predominates over the AT1B receptor in the mouse [13].
Plasma angiotensin II levels
Figure 4 shows plasma angiotensin II levels for animals of each
genotype fed a normal or low sodium diet. During normal diet,
the plasma angiotensin II levels averaged 19.1 4.0 pg/ml and
144.6 5.6 in Agtrla +/+ and Agtrla —/— mice, respectively.
Thus, a marked increase in angiotensin II was observed by
deletion of ATIA receptor. In wild-type mice, there was also a
significant increase during low sodium diet when compared to
normal sodium diet (57.0 17.5 pg/mI, P < 0.05). Of interest,
sodium restriction failed to further increase angiotensin II level in
the mutant mice (122.7 9.6 pg/mI).
ATIA receptor regulation during chronic sodium restriction
We first examined the ATIA receptor regulation during
chronic ECF volume depletion. For this purpose, Northern blot
analysis of AT1A mRNA from wild-type +1+ mice on a normal
diet were compared with data from wild-type mice on sodium
restriction. As shown in Figure 5, the ratio was on average 1:1 in
the kidney and heart, indicating that sodium restriction does not
affect ATIA mRNA in these organs. By contrast, within the
adrenal gland, sodium restriction caused an increase in ATIA
mRNA to levels more than threefold of baseline over levels
obtained during normal sodium diet (Fig. 5).
In targeted mice, in which the Agtrla
promoter drives lacZ transcription, lacZ mRNA within the kidney
and heart was unaffected by dietary sodium restriction. The lacZ
mRNA ratio between normal versus low sodium diet remained 1:1
in the heart and kidney (Fig. 5). Unlike the marked increase in
AT1A mRNA expression seen in wild-type mice, lacZ mRNA did
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Fig. 6. (A.) P-Galactosidase staining of kidney tissues from heterozygotes
(Agtrla!ZI+) and homozygotes (.4gfr1aIIAgtr1ath') carrying oniy one lacZ
allele on normal or low sodium diet. To examine local lacZ activity within the
kidney during dietary sodium restriction, kidney tissue specimens from mice
on normal versus low sodium diet were compared for /3-galactosidase
activities (top panels vs. bottom panels). Whereas in the homozygote (right
two panels), sodium restriction caused a dramatic redistribution of Agtrla
gene expression to arterioles, no such change was observed in the heterozy-
gote, although both these two animals carry one lacZ allele. Thus, the intact
Agtrla allele 'rescues' the heterozygote from manifesting the redistribution
during dietary sodium restriction. Comparing the left two panels and the right
two panels, it was apparent that inactivation of Agtrla by null mutating the
second allele of the heterozygote to produce the homozygote leads to
redistribution of lacZ signal to arterioles; this redistribution is more pro-
nounced during dietary sodium restriction (Counter stained with PAS, mag-
nification X480). (B) Density of 3.galactosidase-positive vascular area in the
renal cortex in heterozygous (AgtrJa'/+) and homozygous (4gtr1aiZ/
AggrlaefP) mice. Density was determined on 3 j.m sections simultaneously
prepared fromA r1a5'/+ mice placed on normal (N = 5) and low sodium
diets (N = 3); and from Ag/na Z/AgtnlastP mice placed on normal (N = 4)
and low sodium diets (N = 3). Values are given as a fraction of cortical area
that is /3-galactosidase-positive. Statistical Comparison was performed be-
tween normal sodium (NS) versus low sodium (LS) diets within the same
genotype, and between +/-- versus
—I— on the same diet. Values are
expressed as means SEM. N = 5 in each group. ns, not significant.
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Fig. 7. In situ hybridization assessing distribution of AT1A mRNA in the
kidney of wild-type mice (Agtrla +1+). AT1A mRNA is typically ex-
pressed in the vascular pole of the glomerulus and is not affected by
dietary sodium restriction in wild-type mice. (counterstained with tolu-
idine blue, magnification x480)
not increase significantly in the adrenal gland of these targeted
mice. Thus, when the AT1A coding exon is replaced with the lacZ
gene, that is, when AT1A receptor is completely inactivated, the
tonic effect of sodium restriction on the A girl a gene transcription
in the adrenal was no longer apparent. An interaction between
angiotensin and AT1A receptor is, therefore, required for dietary
sodium restriction to up-regulate adrenal ATI A transcription.
Although the Agirla gene expression assessed at the whole
kidney level was insensitive to dietary sodium restriction, tissue
staining for lacZ in the homozygotes revealed dramatic up-
regulation of Agirla gene expression in small renal arteries. Thus,
in homozygous targeted Agtrla cZIAgtrJa?fP mice on normal
sodium diet, f3-galactosidase staining was localized only within the
vascular pole of the glomerulus, whereas sodium restriction
intensified the staining that became extensively distributed along
the arterioles (Fig. 6A). Thus, the density of 13-galactosidase-
positive vascular area more than doubled during dietary sodium
restriction in homozygous targeted mice (Fig. 6B). Moreover,
within a given 3-ga1actosidase positive area, the intensity of
positivity was qualitatively substantially higher in specimens from
mice on low as compared to normal sodium diet (Fig. 6A). This
dramatic redistribution in the vasculature was not observed during
salt restriction in heterozygous animals. Thus, the pattern of
-galactosidase staining (Fig. 6A) and the density of /3-galactosi-
dase-positive vasculature (Fig. 6B) in AgtrlaIZ/+ were similar
during normal and low sodium diets (Fig. 6A). These findings
were duplicated by expression of lacZ mRNA within the kidney
examined by in situ hybridization using a lacZ-specific probe (data
not shown). In contrast, in wild-type mice the message for AT1A
mRNA examined by in situ hybridization was still confined to the
vascular pole of the glomerulus and several tubular structures,
even during low sodium diet (Fig. 7).
AT1A receptor regulation in response to depletion of the
receptor
We next examined whether depletion of the receptor per se
provokes a feedback up-regulation of the receptor gene expres-
sion. Importantly, the targeting substitution of the AT1A coding
exon with the lacZ gene, in and of itself, is a form of depletion of
the AT1A receptor. Further, lacZ mRNA is taken as an expres-
sion of Agtrla gene activity as the lacZ is still driven by the Agtrla
promoter. While wild-type mice have two Agtrla alleles, one
AT1A allele is null-mutated and replaced with a lacZ allele in the
heterozygote (Fig. 8A). Northern blot analysis of kidney tissues
revealed, however, that this form of partial ATIA depletion per se
does not activate Agtrla gene expression, as the relative intensity
of AT1A mRNA in the wild-type and heterozygote remained 2 to
1, that is, directly proportional to the number of intact Agtrla
alleles (Fig. 8A). Likewise, complete null mutation of Agtrla allele
from the heterozygote to homozygote did not activate the gene
either, as relative lacZ mRNA in these two groups, which is driven
by the native Agtrla promoter, in the heterozygote and homozy-
gote was approximately 1 to 2, that is, again, directly proportional
to the number of lacZ allele (kidney, Fig. 8A).
The relative intensity of AT1A or lacZ mRNA was also
proportional to the gene copy number in the heart and adrenal
(Fig. 8B). Figure 9 directly compares the level of AT1A mRNA in
the wild-type and lacZ mRNA in the homozygote after normal-
izing these values by the intensity ratio between the two mRNAs
in the heterozygote described above. This comparison found no
difference in mRNA intensity between these two animals in any of
the organs studied. The results indicate that AT1A receptor
inhibition, per Se, does not up-regulate Agtrla gene expression.
Although the Agtrla gene expression assessed at the whole
kidney level was insensitive to targeting inhibition of AT1A
receptor per se, tissue staining for lacZ in the homozygotes
revealed that ATI A receptor inhibition, similar to dietary sodium
restriction, leads to dramatic redistribution of Agtrla gene expres-
sion to small renal arteries. Thus, when the second Agtrla allele
was null mutated from the heterozygote to the homozygote,
A girl a gene expression represented by lacZ staining was now
extensively redistributed to the small renal arteries (Fig. 6A).
Note that, in this particular study, we used homozygous
(AgtrlaIAgtr]a ) mice which carry only one lacZ allele as in
the heterozygote (Agtr1aIZI+). The drastic redistribution to the
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Fig. 8. (A) Northern blot analysis for ATIA mRNA and lacZ mRNA in adrenal tissues from wild-type (AgIrla +1+), heterozygous (Agtr1aaZI+) and
homozygous (Agtr1a/Agfr1aZ) mice. The quantity of these mRNAs normalized for GAPDH mRNA was directly proportional to the number of
alleles from which these mRNAs are derived. Wild-type, heterozygous and homozygous mice are depicted as +7+, +7— and —I—, respectively. The ratio
between AT1A mRNA and lacZ mRNA determined in the heterozygotes was used as a normalization factor in direct comparison between AT1 mRNA
from wild-type and lacZ mRNA from homozygotes. (B) Northern blot analysis for AT1A mRNA and lacZ mRNA in kidney, heart and adrenal tissues
from wild-type (Agtrla +1+), heterozygous (Agtr1dI+) and homozygous (Agtr1a""7IAg(r1a") mice on normal (NS) and low (LS) sodium diets. The
three left lanes duplicate those in Figure 8A. Wild-type, heterozygous and homozygous mice are depicted as +7+, +7— and —I—-, respectively.
small arterial walls of the hornozygote must, therefore, reflect pressure (Fig. 10). During normal sodium diet, +7+,Agtrla +7—
alteredAgtrla promoter activity, and .Agtrla —I— mice had values typical for these wild-type,
In examining the potential intermediary mechanism leading to heterozygous and homozygous mice, averaging 107 2 mm Hg,
up-regulation of Agtrla promoter activity not linked to a local 92 I (P < 0.01, vs. wild-type) and 62 1 (P < 0.001, vs.
ligand-receptor interaction per Se, we measured systemic blood heterozygous mice), respectively. During the low sodium diet,
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Fig. 9. Levels of AT1A mRNA in wild-type (AgIrla +1+) and lacZ mENA
in the homozygote (AgIrla IAgtr1aZ). For this comparison, values of
ATIA mRNA and lacZ mRNA were normalized against the intensity
ratio between the two mRNAs in the heterozygote. No difference in
relative mRNA intensities between these two groups was found in any of
the organs studied. Statistical comparison was performed between +1+
versus —I— mice, which were on normal sodium diet. Values are expressed
as means SEM. N = 5 in each group. ns, not significant. Fig. 10. Mean arterial pressure during normal and low sodium diets in
wild-type (+1+), heterozygous (+1—) and homozygous mice (—I—). Mean
arterial pressure in Agtrla —I—, homozygous mice was significantly lower,
on average by —30 mm Hg, than in .4gtrla +1—, heterozygous mice.
Whereas dietary sodium restriction did not affect systemic blood pressure
in +1+ wild-type mice, sodium restriction in AgIrla —I— mice led to a
substantial fall in blood pressure, on average by —20 mm Hg. Statistical
comparison was performed between normal sodium (NS) versus low
sodium (LS) diet within the same genotype, and between +1+ versus +1—
and +1— versus —I— on the same diet. Values are expressed as means
SEM. N = 5 in each group. ns, not significant.
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blood pressure averaged 105 5 mm Hg (P > 0.7, vs. normal
diet), 77 4 (P < 0.01, vs. normal diet) and 44 5 (P < 0.005,
vs. normal diet), respectively, in these animals. Thus, whereas
dietary sodium restriction did not affect systemic blood pressure in
+1+ mice, sodium restriction in Agtrla —I— mice led to a
substantial fall, on average by -—20 mm Hg. Agtrla +1— mice
showed an intermediate pattern in basal level and in the respon-
siveness to sodium restriction. A tight association between renal
vascular Agtrla transcriptional activity and renal perfusion pres-
sure is, therefore, established by these blood pressure measure-
ments. The marked fall in blood pressure resulting from complete
depletion of ATIA receptor protein from heterozygous to ho-
mozygous state (+/— on NS vs. —I— on NS in Fig. 10) was
accompanied by a marked increase in p-galactosidase positivity in
renal arterioles (+1— on NS vs. —I-- on NS in Fig. 6B). Similarly,
dietary salt restriction in homozygotes led to a further substantial
fall in blood pressure (NS vs. LS in —I—; Fig. 10) together with a
further substantial increase in j3-galactosidase positivity in renal
arterioles (NS vs. LS in -/—; Fig. 6B).
DISCUSSION
In the present study, dietary sodium restriction was shown to
up-regulate Agtrla gene expression in the adrenal gland of
wild-type mice. This finding reiterates those already found in rats
by other investigators [21—23], although non-rodent mammals
were reported to behave somewhat differently [24, 25]. Of note, an
infusion of Ang 11 in rats in vivo was shown by Regitz-Zagrosek et
al [26] to up-regulate adrenal AT1 mRNA. The up-regulation of
Mg II receptor in the adrenal during sodium restriction is,
therefore, attributed to a high Ang II. Our observations echo this
notion. In mice homozygous for targeted null mutation of Agtrla
gene, dietary sodium restriction failed to lead to the marked
increase in mRNA observed inAgtrla-intact wild-type mice. Since
systemic blood pressure fell markedly in the homozygotes on low
sodium diet, it is apparent that blood pressure has little influence
on the transcription of Agtrla in the adrenal. Instead, a direct
interaction between Ang II and the AT1 receptor is involved in
the up-regulation of adrenal AT1A mRNA during dietary sodium
restriction. As discussed below, a different mechanism regulates
the AT1A in the kidney.
In Agtrla null mutant mice, sodium restriction caused a
dramatic up-regulation of the Agtrla gene expression in the small
arteries within the kidney. This phenomenon was not seen in
wild-type mice, indicating that this adaptation in the kidney does
not involve angiotensin-ATI receptor interaction. Our previous in
situ hybridization studies [27] revealed that only an extremely low
level of AT1B mRNA expression is present in the kidney.
Moreover, in AT1B gene targeted mice recently developed in our
laboratory [28], no AT1B gene activity assessed by 13-galactosidase
staining was demonstrable within the kidney with or without
chronic sodium restriction. Thus, ATIB plays only a subtle role in
the overall quantity of AT1 receptor within the small renal
arteries with or without sodium restriction. Of note, systemic
arterial pressure decreased in homozygous but not in wild-type
mice (Fig. 10). A tight correlation betweenAgtrla gene expression
assessed by /3-galactosidase positivity was also demonstrated when
an intact Agtrla allele was removed from heterozygotes to pro-
duce homozygotes. Thus, this mode of experimental depletion of
ATIA receptor caused a reduction in systemic blood pressure on
average by —30 mm Hg. Again, this reduction in blood pressure
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Fig. 11. 13.Galactosidase staining of kidney tissues from homozygotes
(AgtrlaklAtrlalz) placed on mineralocorticoid plus salt. In homozy-
gous mice given mineralocorticoid plus salt, systemic blood pressure was
normalized up to normal baseline, on average, 105 5 mm Hg (N = 6,
P < 0.01 VS. vehicle), while mean arterial blood pressure for the mice given
vehicle alone was still 64 1 mm Hg (N = 4). 13-galactosidase staining
along the small arteries within the kidney was markedly diminished (upper
panel). Lower panel shows representative fl-galactosidase staining ob-
tained from a mouse given vehicle alone (counter stained with PAS,
magnification x480).
was accompanied by a f3-galactosidase positivity that is signifi-
cantly higher in the vasculature of homo- than heterozygous mice
(Figs. 6A and 6B). Collectively, these observations suggest that,
for a low sodium diet to induce up-regulation of Agtrla gene
transcription in renal resistance vessels, an appreciable reduction
in renal perfusion pressure is required. To further test this notion,
we employed an experimental protocol of mineralocorticoid plus
salt supplementation to experimentally raise renal perfusion
pressure in homozygous mice carrying two lacZ alleles. In
Agtrla—I— mice given mineralocorticoid plus salt, mean arterial
blood pressure increased to 105 5 mm Hg (P < 0.01, vs.
vehicle), that is, a level comparable to those found in wild-type
mice on normal diet, and /3-galactosidase-positive cells along the
small arteries within the kidney were markedly attenuated (Fig.
11). The results support the notion that renal perfusion pressure
indeed regulates the Agtrla promoter in the renal arteriolar wall.
Given the significant difference in systemic blood pressure be-
tween heterozygous and homozygous AT1A null mutant mice
noted in this and other studies [4—6], it is reasonable to assume
that the marked difference in Agtrla gene expression between
homozygous Agtrla null mutants on low versus normal sodium
diet is, indeed, functionally significant. Thus, sodium restriction in
normal mice activates a highly efficient feedback mechanism
involving AT1 receptor as well as renin, which collectively restores
systemic blood pressure to near baseline [29, 30].
Targeting replacement of the AT1A coding exon with a re-
porter gene revealed that when AT1 receptor protein is experi-
mentally depleted, activation of Agtrla gene occurs within the
small arteries of the kidney. The present study indicates that such
a regulatory mechanism for AT1 does exist within the kidney, and
the mechanism acts in a fashion compatible with homeostatic
need. Thus, when dietary sodium intake is restricted, appropriate
homeostatic adjustments need to take place, since, otherwise, as
revealed by the present study, hypotension will ensue. Similarly,
when the quantity of ATI falls, a homeostatic mechanism comes
into play to restore the receptor by activating the Agtrla gene. In
this context, regulation of AT1A has a goal similar to that of renin
regulation. Obviously, not all adjustments occurring within the
renin-angiotensin system during low sodium intake are synergistic
or complementary or augment the actions of Ang II. Indeed, as
discussed earlier, Ang II per se has a negative impact on the
quantity of active cell surface AT1 receptors [31]. The in vivo renal
perfusion pressure-dependent mechanism for AT1 regulation
documented herein is, therefore, considered as an important
homeostatic mechanism counteracting this negative effect of Ang
II.
In conclusion, the present study demonstrated that the renal
angiotensin type 1 receptor expression, like renal renin, is regu-
lated by systemic physiologic parameters, such as perfusion pres-
sure rather than a local ligand-receptor feedback, which enact the
homeostatic need of the body in vivo.
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